XML 62 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Stock Options Awards and Restricted Stock Grants (Details) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 1.13 $ 2.03
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 1,063,482  
Weighted average exercise price, beginning balance $ 2.62  
Options outstanding, granted 929,335  
Weighted average exercise price, granted $ 1.13  
Options outstanding, vested and issued  
Weighted average exercise price, vested and issued  
Options outstanding, Terminated (460,378)  
Weighted average exercise price, Terminated $ 1.58  
Options outstanding, ending balance 1,532,439  
Weighted average exercise price, ending balance $ 2.02  
Weighted average contractual terms 9 years  
Options outstanding, aggregate intrinsic value $ 27,548  
Options outstanding, exercisable 887,894  
Weighted average exercise price, exercisable $ 2.62  
Weighted average contractual terms, exercisable 8 years 6 months  
Options outstanding, aggregate intrinsic value, exercisable $ 14,958  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 32,100  
Weighted average grant date fair value, beginning balance $ 1.23  
Non-vested stock awards, granted 25,000  
Weighted average grant date fair value, granted $ 1.06  
Non-vested stock awards, vested and issued (12,100)  
Weighted average grant date fair value, vested and issued $ 1.84  
Non-vested stock awards, Terminated (20,000)  
Weighted average grant date fair value, Terminated $ 0.88  
Non-vested stock awards, ending balance 25,000  
Weighted average grant date fair value, ending balance $ 1.06